Dr. Hammett will be available for new patient consultations via phone and available for virtual online telemedicine sessions conducted via Zoom. In office visits are by appointment only at this time. Please note that we are taking extra time to disinfect our adjusting tables and all surfaces thoroughly between each patient. We are also wearing masks and disinfecting our hands thoroughly between each patient. If you have a mask, please wear it during your visit to the office. Please give us a call to schedule or if you have any questions. Thank you!
If you are not yet a member of our practice, Please call to schedule at FREE 15 minute consult with Dr. Hammett get guidance on if this lab test is best for you or to discuss any questions you may have with any of the labs offered.
NOTE: Results of the labs acquired by you are not a diagnosis of your condition. Your result do not establish you as a patient of Dr. Hammett. Your results are not a recommendation to self diagnose nor are the results meant to self treat with any medications or supplementation. Please consult with Dr. Hammett if you would like to have an in depth interpretation of your lab results and establish a comprehensive treatment plan.
Brand: Genova Diagnostics - Stool Test
Have you been struggling with gas, bloating, abdominal pain,
diarrhea or constipation? Find out if your symptoms are due to inflammatory
bowel disease, food intolerance or other intestinal health issues with GI Effects Comprehensive Stool Profile. This stool analysis, done in the privacy of your own home, can reveal important information about the root cause of many common gastrointestinal problems that can lead to Inflammatory Bowel Disease, Crohns Disease, Irritable Bowel Disease, malabsorption and more.
The GI Effects® Comprehensive Stool Profile is a group of advanced stool tests that provide immediate, actionable clinical information for the management of gastrointestinal health. Utilizing cutting-edge technologies and biomarkers, this profile offers valuable insight into digestive function, intestinal inflammation, and the intestinal microbiome.
The GI Effects Comprehensive Stool Profile Biomarkers
The biomarkers on the GI Effects Comprehensive Profile reflect the 3 key functions of gut health arranged in the "DIG" format: Digestion/Absorption, Inflammation/Immunology, and the Gut Microbiome:
Pancreatic Elastase-1 is a marker of exocrine pancreatic function.
Products of Protein Breakdown are markers of undigested protein reaching the colon.
Fecal Fat is a marker of fat breakdown and absorption.
Calprotectin is a marker of neutrophil-driven inflammation. Produced in abundance at sites of inflammation, this biomarker has been proven clinically useful in differentiating between Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).4,5
Eosinophil Protein X is a marker of eosinophil-driven inflammation and allergic response.
Fecal Secretory IgA is a marker of gut secretory immunity and barrier function.
Fecal Occult Blood Test detects hidden blood; fecal immunochemical testing (FIT) has been recommended by the American College of Gastroenterology as the preferred noninvasive test for colorectal cancer screening/detection.
Metabolic indicators, including short-chain fatty acids and beta-glucuronidase, demonstrate specific and vital metabolic functions performed by the microbiota.
Commensal Bacteria demonstrate the composition and relative abundance of gut organisms.
More than 95% of commensal gut organisms are anaerobic and are difficult to recover by traditional (aerobic) culture techniques.
GI Effects assesses a set of 24 genera/species that map to 7 major phyla.
Bacterial and mycology cultures demonstrate the presence of specific beneficial and pathological organisms.
Bacterial and mycology sensitivities are provided for pathogenic or potentially pathogenic organisms that have been cultured. The report includes effective prescriptive and natural agents.
Parasitology includes comprehensive testing for all parasites on every parasitology exam ordered.
GI Effects provides microscopic fecal specimen examination for ova and parasites (O&P), the gold standard of diagnosis for many parasites.
6 Polymerase chain reaction (PCR) targets detect common protozoan parasites including Blastocystis spp. with reflex subtyping 1-9, Cryptosporidium parvum/hominis, Cyclospora cayetanensis, Dientamoeba fragilis, Entamoeba histolytica, and Giardia. PCR for organisms is emerging as a highly sensitive method for infectious organism detection.
Selection of a one-day or three-day sample collection is based on the clinician's clinical index of suspicion for parasitic infection. If there is no/low suspicion, a one-day sample will likely be adequate. For high suspicion, a three-day sample collection is optimal.